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Abstract - General anesthesia is well known to
offer physicians access to a broad variety of
invasive procedures otherwise deemed too
risky. Anesthesia machines provides the means
for anesthetizing patients safely in the hospital
operating room. However, these devices are
increasingly unable to meet the demands and
needs outside of the hospital. Developing
countries struggle to purchase and maintain
these costly devices, leading to a 40-fold
increase in anesthesia-related deaths compared
to developed countries. Small-office practices
in the United States experience significantly
poorer anesthesia outcomes and increased legal
claims
versus
their
larger
hospital
counterparts, resulting in 60% more
anesthesia-related deaths.
Environmental
impacts and global health concerns from the
emitted anesthetic gases have brought into
serious question the prevailing notion that
unchecked emissions were sustainable. These
factors can all be attributed to anesthesia
machine design and technology having the
primary intended use in the traditional
operating room. The long-term goal of this
work is to develop technologies in anesthesia
that expand its safe use, decrease underlying
costs, and reduce the total emissions. The
immediate objective of this work is to create a
feedback-controlled anesthetic gas vaporizerscavenger system and evaluate its performance.
The central hypothesis is that the combined use
of mesoporous materials and feedback control
provide the opportunity for repeatable capture
and release of expired anesthetic gases during
anesthesia delivery. Our rationale is that such
a device will help reduce the amount of
anesthetic needed while simultaneously offering
improved control over the delivery of anesthetic
gases.

I. INTRODUCTION
Anesthesia is a critical component of most surgical
procedures. General anesthetics cause patients to
lose consciousness and sensation via suppression
of the central nervous systems. Anesthesiologist
accomplish this through either intravenous agents
or inhalational agents. Delivery of inhalational
agents typically necessitates the use of combined
ventilator and agent vaporizer, simply known as an
anesthesia machine. Anesthesia machines have
undergone a several major revisions in their design
for both practical and safety reasons. The modern
anesthesia machine design is a variant of the Boyle
anesthesia machine developed in 1917, with the
core design today being identical but with the
addition of device and patient monitoring and
automated safety systems.1-3
These incremental improvements on the anesthesia
machine have yielded obvious benefits to the
standard operating room. Deliberate addition of
safety features combined with integrated patient
monitoring has led the field of anesthesia from one
of the riskier fields in medicine to one of the safer,
with 1 in 1,000 deaths in the 1940s, 1 in 10,000 in
the 1970s, and finally 1 in 100,000 by the turn of
the century.4–7 However, these improvements are
not without their unaddressed problems. Access to
proper anesthetic care on a global scale remains
shockingly low, with 5 billion individuals having
inadequate or no access.8 On a more local basis,
the expansion of anesthesia delivered in smalloffice practices as led to a sudden increase in
preventable complications.9–11 Last, the emission
of these inhalational agents is becoming an
increasing concern as the direct and indirect
environmental impact is being better understood
and quantified.12–16 Inherently these issues are
multi-faceted, however they can in large part be
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attributed to the current design of the anesthesia
machine.
These factors are the basis for identifying and
improving a variety of components of the
anesthesia machine to ultimately expand the areas
of use and reduces the negative impacts imposed
by inhalational agent emissions. It is the goal of
this dissertation to broaden the body of knowledge
related to inhalational agent monitoring, reversible
inhalational capture, and design and modelling of
these systems.
II. ISSUES IN ANESTHESIA
Alongside the need for patient monitoring, the
ability to safely scavenge expired anesthetic gases
from the anesthesia machine and away from
clinicians remains another hurdle outside of the
hospital.17,19,20 This hurdle again encourages the
use of TIVA over inhalational anesthetics at both
increased financial cost and risk of undetected
respiratory depression.18 Even with appropriate
anesthetic scavenging or respiratory monitoring, a
secondary impact of inhalational anesthetics is the
negative environmental impact.13–15 Because the
three primary volatile anesthetics (isoflurane,
sevoflurane, and desflurane) undergo negligible
metabolism in vivo, they are largely exhaled and
subsequently scavenged and vented by anesthesia
machines to hospital waste gas systems which
release these gases to the atmosphere. Studies
have estimated that inhaled anesthetic gases
contribute upwards of two-thirds of surgical
procedure greenhouse gas emissions and 98% of
the ozone depleting compounds.16 While not a
direct impact to the patient in the operating room,
further studies estimate that greenhouse gas
emissions associated with US health care activities
cause the loss of 123,000-381,000 disabilityadjusted life-years annually, well exceeding the
44,000-98,000 who die annual due to preventable
medical errors.15 In anesthesia, volatile agent
release marks the primary environmental burden
and are therefore the highest priority for reduction.
1.3 Current Design of Anesthesia Machine

A detailed understanding of the anesthesia
machine is needed to identify and address the
shortcomings associated with current delivery of
anesthesia and will therefore be reviewed. In the
most basic sense, the primary role of the anesthesia
machine is to deliver fresh oxygen and anesthetic
gases to patients during surgery and
simultaneously remove exhaled carbon dioxide.
This process can be broken down into two sections
of the machine: high-pressure and low-pressure
(Figure 1). The high-pressure portion of the
machine begins with oxygen, air, and nitrous oxide
entering the machine from either a hospital
supplied pipeline or a gas cylinder. Pressure
regulators drop the pressure down to
approximately 50 psi. A junction is placed
between the nitrous oxide and oxygen lines to fit a
fail-safe valve. This valve ensures that nitrous
oxide will only flow if there is adequate pressure
in the oxygen line, a first step in preventing the
accidental delivery of hypoxic mixtures to patients
in the event of an oxygen line failure. In tandem
with this fail-safe valve, a pressure sensor is often
affixed to the oxygen line to additionally alarm in
the event of a sudden pressure drop. Moving
farther downstream, variable flow control valves
allow the clinician to determine the amount of
fresh gas entering the vaporizers. Older model
anesthesia machines incorporated a coupling chain
between the oxygen and nitrous oxide lines to
ensure again that a clinician does not erroneously
deliver hypoxic mixtures.
More modern
anesthesia machines accomplish this through
computer monitored controls, albeit with
limitations and still concern for accidental
generation of hypoxic conditions.21
As fresh gas moves into the low-pressure leg of the
system, it pass through an anesthetic vaporizer.
Modern vaporizers are typically variable-bypass
vaporizers. These function by allowing a small
amount of fresh gas to by bypassed through a tank
filled with the volatile anesthetics. Control over
the final concentration is determined by how much
fresh gas is bypassed through the tank. Because
the vapor pressure of each volatile anesthetic is
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Figure 1 - Schematic of gas flow in a standard anesthesia machine, including gas delivery, common patient breathing circuits, and waste
anesthetic gas scavenging.

different, each vaporizer is carefully calibrated for
each specific anesthetic agent.
Advanced
vaporizers additionally utilize an expansion rod
that will further vary the bypass of flow as
temperatures change.
This anesthetic rich gas now enters one of three
breathing circuit configurations: open, semiclosed/semi-open, or closed. In an open breathing
circuit, also known as Mapleson breathing circuit,
anesthetic rich gas is delivered to the patient at

inspiration, with an adjustable pressure limiting
(APL) valve then immediately removing the gas to
a waste stream during exhalation. Open breathing
circuits are the simplest of breathing circuits,
however, fail to reuse any of the exhaled volatile
anesthetic gas. Semi-closed/semi-open breathing
circuits partially address this by recirculating
exhaled volatile anesthetic back into the
inspiratory limb. However, this necessitates the
addition of a carbon dioxide scrubber to avoid
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hypercapnia. These breathing circuits still waste
anesthetic rich gas at the same rate is the incoming
fresh gas flow. The differentiation between semiclosed and semi-open is based on the fresh gas
flows and subsequently the amount of rebreathing.
Semi-closed systems have lower fresh gas flow
with some rebreathing, while semi-open systems
have higher fresh gas flow and little to no
rebreathing. Fully closed systems have fresh gas
flows that equally match the patient uptake,
requiring no addition of a waste stream. This
necessitates diligent patient vitals monitoring to
match physiologic needs as well as difficulty in
accurately titrating the correct inspired anesthetic
gas concentration.
The ventilator that drives the gas coming from the
anesthesia machine can exists in a variety of
locations in the breathing circuit. Mechanical
ventilation methods range from spontaneous
respiratory support to complete machine support;
however, all ventilators function by increasing the
pressure inside the inspiratory limb periodically to
facilitate fresh gas entering the lungs. At the
junction of the inspiratory and expiratory limb,
also known as the Y-piece, gas is sampled to
monitor respiratory gases such as oxygen and
carbon dioxide as well as anesthetic gases
including nitrous oxide and volatile anesthetic
agents. Respiratory flow is also monitored at
either the Y-piece or through the ventilator to
ensure proper ventilation.22
III. Reduction of Anesthetic Gas Emissions
Anthropogenic caused climate change has been
receiving a distinct increase in attention from both
the public and at research institutions. Carbon
dioxide remains the main player in greenhouse gas
contribution, representing more than 76% of the
total greenhouse gas emissions, primarily from
fossil fuel combustion. Fluorinated hydrocarbons,
the category of molecules that volatile anesthetic
gases fall under, represent a much smaller fraction
of greenhouse gas emissions, representing only 2%

of the total volume. However, due to the chemical
stability of these molecules and subsequent long
half-life, most of these gases possess a higher
global warming potential compared to carbon
dioxide and impose a significant impact on climate
change.23
Waste volatile anesthetic gases have little to no
economic value and are therefore vented from the
hospital
directly
into
the
atmosphere.
Consequentially, several technologies have been
proposed or developed to remove these
compounds, including adsorption, absorption,
condensation,
membrane
separation,
or
decomposition processing. Of these technologies,
adsorption and absorption technologies have seen
the most application, in part due to the high
operating and capital costs of the other described
methods. Despite developments in adsorptive and
absorptive methods for capture and regeneration of
waste volatile anesthetic gases, the field remains in
its infancy. Few publications exist that describe
sorption or breakthrough properties of volatile
anesthetics with porous media, with most older
publications focusing on volatile anesthetics that
are no longer used.24-26 Other publications review
methods for treating waste gases containing
volatile organic compounds, however none of
these publications are specific to volatile
anesthetic emissions and considerations specific to
that field.27 As a result, there exists a broad gap in
knowledge for material
characterizations
describing reversable volatile anesthetic gas
capture in both static and dynamic conditions.
1.5.1 Principles of Gas Adsorption
The retention or release of substances onto porous
media, especially from a mobile (liquid or
gaseous) to a solid phase, is a well-studied field.
The curve that describes the retention of the
substance onto the porous media at various
concentrations is called the “sorption isotherm”
and is used to predict the mass transfer of the
substance beyond the empirical study. This is
described as the solute concentration of the
compound compared to the concentration of the

5

compound on the solid particles, described as P
and P0 respectively. Ideally the sorption isotherm
would be represented as time-independent
capacity, allowing all various reactions to meet
equilibrium. However, because many of the intramolecular retention and release mechanisms are
strongly kinetically controlled on time scales
beyond practical use, many sorption isotherms will
specify time-dependence.27 The kinetics of these
mechanisms can also vary drastically between
adsorption and desorption, introducing hysteresis
to the sorption isotherm plots.
Figure 3 - Classification of sorption isotherm hysteresis.

Figure 2 - Sorption isotherm characteristics as recommended by
IUPAC.28

Based on commonly observed behaviors, sorption
isotherms have been described in 6 main shapes by
IUPAC.
These types of isotherms are
characteristic of adsorbents that are microporous
(Type I), microporous (Type II, III, and VI), or
mesoporous (Types IV and V) are show in Figure
2.28 The hysteresis found in Type IV and V are
further classified and are shown in Figure 3.
Within these sub-classifications, H1 is reflective of
porous materials consisting of cylindrical pore
channels or spherical pores. Type H2 is reflective
of materials with disordered pore size and shape,
especially pore with high tortuosity within the
pore. Type H3 and H4 hysteresis both are
indicative of slit-shaped pores, with H3 showing
no limit to the adsorption at high pressure.

Determining these types of isotherm types is
typically done empirically but can provide further
insight when used to determine an appropriate
model to infer information beyond the collected
data. The simplest adsorption isotherm model
describes the amount of surface adsorbate as
directly proportional to the partial pressure of the
gas. The model typically only applies at relatively
low concentrations due to the implication that
there is no competitive behavior from one
adsorbate molecule to another.
Thus, the
equilibrium of the adsorbate concentrations to the
adsorbed phase can simply be described a linear
expression also known as Henry’s Law.29
𝑞𝑞𝑒𝑒 = 𝐾𝐾𝐾𝐾

Where qe is the amount of adsorbate at
equilibrium, K is an equilibrium constant, P0 is the
maximum tested pressure, and P is the pressure of
interest.
Langmuir adsorption was derived by Irving
Langmuir to describe the gas-solid adsorption as
well as to quantify the adsorptive capacities of
various adsorbents. The model also assumes
monolayer adsorption at the surface of the
adsorbate.
As a result, this is graphically
represented by a Type I isotherm, whereas the sites
for adsorption fill, the total surface capacity will be
met and no further adsorption can take place, and
can be expressed as the following:
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𝑞𝑞𝑒𝑒 =

𝑄𝑄0 𝑏𝑏𝐶𝐶𝑒𝑒
1 + 𝑏𝑏𝐶𝐶𝑒𝑒

Where Q0 is the maximum monolayer coverage
capacity, b is the Langmuir isotherm constant, and
Ce are the chosen equilibrium concentrations.30
Herbert Freundlich gave provided a basis for
modelling reversible adsorption on heterogenous
surfaces that were additionally not restricted to the
formation of a monolayer on the surface. This has
been found particularly useful for modelling
organic compounds on activated carbon and
molecular sieves.31 The non-linear form of the
Freundlich isotherm can be described as:
1�
𝑛𝑛

𝑞𝑞𝑒𝑒 = 𝐾𝐾𝐹𝐹 𝐶𝐶𝑒𝑒

Where Kf is the Freundlich isotherm constant
related to adsorption capacity, and n is the
adsorption intensity.
These models provide good insight into the
equilibrium capacity pairings of gas-solid phase
sorption systems, however as previously
mentioned, poses difficulty in accurately described
the anticipated kinetics in dynamic systems. When
describing the sorption of an adsorbent through a
fixed bed of adsorbate, describing and modelling
the breakthrough curve is of primary interest. Fast
kinetics implies a steep breakthrough curve with
rapid adsorption onto the surface of the adsorbate,
while slow kinetics will lead to a distended
breakthrough curve. Additionally, regardless of
any hysteresis in the sorption isotherm, the
breakthrough behavior of adsorption versus
desorption are widely different in almost all cases.
Modelling of breakthrough curves requires in
depth knowledge of the sorption isotherm, particle
density and void fraction, kinetics, and fixed-bed
dynamics. Experimental data can be used to
generate empirical models; however, care should
be taken when making predictions as either
conditions or materials change. The WheelerRobell equation is a simple empirically informed
equilibrium model that has had notable success.

The equation-based model applies to any isotherm
form and retains simplicity by neglecting the
impacts of axial dispersion.32
II. METHODS
Sorption Isotherm of Porous Materials with
Anesthetic gases
Two generalized tests were performed to better
understand the general behavior of activated
charcoal and anesthetic gases. The first test
consisted of a 5 L/min flow of oxygen containing
5% isoflurane (Piramal Healthcare Limited,
Andhra Pradesh, India) to be passed through a
cylindrical vessel containing 42 grams of activated
charcoal (Oxpure 1220C-75, Oxbow Activated
Carbon, West Palm Beach, FL) until 0.5%
isoflurane pushed through (approximately 10
minutes). The vessel was sealed and weighed to
determine the amount of anesthetic gas adsorbed
onto the surface of the charcoal. Next, a gas flow
containing pure oxygen was pushed through the
vessel at a rate of 2 L/min and the concentration of
anesthetic gas leaving the vessel was measured.
The same process was repeated with non-porous
beads as a control. A second test consisted of a
smaller vessel containing 10 grams of partiallysaturated activated charcoal (total weight of 14
grams) placed between the Y-piece of an
anesthesia circuit and a mechanical lung simulator
(TTL Michigan Testlung, Michigan Instruments,
Grand Rapids, MI). This test lung was then driven
using a ventilator and 100% oxygen, with the
concentration of isoflurane between the vessel and
test lung being monitored.
A control was
performed with non-porous beads.
Anesthetic Gas Scavenger-Vaporizing Device
Test
An initial proof-of-concept prototype was
demonstrated and fitted within the rebreathing
circuit of a current anesthesia. This system
consisted of a housing with two chambers, one
fitted with a charcoal cartridge, and the other open
to free gas flow. A gear with a semicircular
opening was actuated externally to determine
which chamber, or combination of chambers, had
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fresh gas traveling through from the anesthesia
machine to the simulated lung. In addition,
differential pressure sensors were attached at both
chambers to detect inhalation and exhalation.
Anesthetic gas concentration measurements from
a standard infrared gas bench was used for basic
feedback control. A microcontroller controlled the
orientation of the gear valve to titrate the
anesthetic concentration based on breath detection,
anesthetic gas concentration, and a user input for
desired anesthetic concentration using a
rudimentary hysteresis controller.
III. RESULTS
A. Sorption Isotherm of Porous Materials
Isoflurane was released at concentrations suitable
for anesthesia maintenance for a significant
amount of time, approximately 10 minutes (Figure
4). Ventilation was also tested to investigate more
dynamic conditions where the device was
ventilated with a test lung (Figure 5). Once
saturated, the activated charcoal had absorbed
approximately 60% of its total weight in isoflurane
and was capable of repeatedly reflecting 10% of its
total weight in isoflurane or about 3.2 mL of liquid
isoflurane. This volume of isoflurane capable of
being reflected is the equivalent of anesthesia
maintenance at 1 MAC for 1 hour at a fresh gas
flow rate of 1 liter per minute.
B. Prototype Device Design
A prototype was successfully created and could
perform the basic desired functions. Specifically,
inspiratory and expiratory flows were detected and
a basic “bang-bang” feedback control was
implemented to achieve the desired concentration.
Once the charcoal had been saturated from a mock
anesthesia induction, the controller was able to
maintain average isoflurane concentrations within
0.2% by volume of the user set point (1.2% by
volume).

that absorbs, holds, and releases anesthetic gases
back to the patient. Not only would this remove the
need for an anesthetic scavenging system, but it
would also significantly decrease the cost of
anesthetic maintenance by reducing the amount of
gas vaporized. Preliminary data has shown that 40mesh activated carbon can capture anesthetic gases
and release them with reversed flow at a
concentration high enough for sedation. By
combining this material with a novel breathing
circuit design, we will remove the need for a
scavenging system and expand the environments
in which anesthesia can be used. Success in this
research will ultimately reduce the cost,
infrastructure, and expertise needed to deliver
general anesthesia. By doing this, the global access
to anesthesia and surgical will be greatly
increased, reducing the suffering in the world.

Figure 4 The observed concentration of isoflurane leaving the
vessel containing 40 grams of saturated activated charcoal as the
flow was reversed at 2 liters per minute. The activated charcoal
(black) allowed for the gradual released of isoflurane compared to
the control (red) containing no activated charcoal.

IV. DISCUSSION
Activated carbon has been shown to readily absorb
and release anesthetic gases. Creating a system
using this material would allow for the
implementation of an activated carbon reflector

Figure 5 - The observed concentration of isoflurane during
ventilation between 10 grams of activated charcoal and the test
lung. Activated charcoal (grey) allowed for the gradual released of
isoflurane compared to the control (pink). A running average is
shown for both the activated charcoal (black) and control (red).
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Figure 6 - Schematic of the proposed Scavenging-Vaporizing System and how it functions with a commercial ventilator. Within the system
exists two columns alternating in function between vaporizer and scavenger. These roles are determined through the actuation of valves. Not
shown is an anesthetic gas reservoir used if neither column can deliver the set concentration of anesthetic, as well as a fresh gas bypass for
when no anesthetic is needed.

Future designs will include a dual column system
that oscillates between a vaporizing column and a
recovering column (Figure 6). The system is
designed so that it can be used with the circle
breathing system and ventilator of a typical
anesthesia machine. In this system one column
vaporizes anesthetic gas into the fresh gas flow,
while the other column simultaneously scavenges
exhaled anesthetic gas from the waste stream.
When either the vaporizing column begins to
deplete, or the scavenging column begins to fully
saturate, a series of valves reverse the roles of each
column and continue the process indefinitely. A
fresh gas bypass will also be included to both
titrate the vaporizing column accordingly and
allow for pure oxygen delivery when anesthetic
gas is no longer needed. A feedback controller
based off an anesthetic gas concentration sensor at
the inspiratory limb of the proposed system will
further control the fresh gas bypass for increased
accuracy and stability. By placing the feedback
sensor in the inspiratory limb, the patient remains
out of the feedback loop, thereby avoiding
regulatory hurdles associated with patient-

included feedback control systems like targetcontrolled infusion. If both columns are depleted
and can no longer maintain set anesthetic gas
concentrations, a reservoir of anesthetic gas
separate from the columns will be used to deliver
anesthetic gas and re-saturate the entire system.
This system will not require any additional work
from the clinician as it will be designed to maintain
an anesthetic gas concentration set by the clinician,
similar to conventional anesthetic gas vaporizers.
However, unlike conventional anesthetic gas
vaporizers, this system limits clinicians to a single
volatile anesthetic for each case and requires that
each column be replaced between cases. While
there will still be some remaining volatile
anesthetic gas in each discarded column, the
overall anesthetic gas used will remain
substantially lower.
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